C WorldWide Group’s Stemline Therapeutics, Inc. STML Stock Holding History

C WorldWide Group’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-998,677	Closed	-$4.83M	–	91
2020 Q1	$4.83M	Hold	998,677	–	–	0.07%	57
2019 Q4	$10.6M	Hold	998,677	–	–	0.13%	47
2019 Q3	$10.4M	Buy	998,677 +140,595	+16%	+$1.84M	0.13%	49
2019 Q2	$13.1M	Buy	858,082 +500,000	+140%	+$7.23M	0.16%	46
2019 Q1	$4.6M	Buy	358,082 +225,654	+170%	+$2.55M	0.06%	62
2018 Q4	$1.26M	Sell	132,428 -46,981	-26%	-$609K	0.02%	96
2018 Q3	$2.98M	Sell	179,409 -34,297	-16%	-$550K	0.04%	85
2018 Q2	$3.43M	Buy	213,706 +43,711	+26%	+$780K	0.05%	82
2018 Q1	$2.6M	Sell	169,995 -25,442	-13%	-$397K	0.04%	77
2017 Q4	$3.05M	Buy	195,437 +35,437	+22%	+$474K	0.04%	73
2017 Q3	$1.78M	Buy	+160,000	New	+$1.5M	0.03%	96
2015 Q1	–	Sell	-21,350	Closed	-$364K	–	141
2014 Q4	$364K	Hold	21,350	–	–	0.01%	100
2014 Q3	$265K	Buy	+21,350	New	+$263K	﹤0.01%	103

C WorldWide Group's STML Position: Q2 2020 in Review

C WorldWide Group sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 998,677 shares — an estimated $4.83M sold.

C WorldWide Group first reported a position in STML in Q3 2014 and held it in 13 quarters. The position peaked at $13.1M in Q2 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

C WorldWide Group reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
C WorldWide Group sold 998,677 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $4.83M.
C WorldWide Group first reported a position in Stemline Therapeutics, Inc. in Q3 2014 and held it in 13 quarters.
C WorldWide Group's Stemline Therapeutics, Inc. position peaked at $13.1M in Q2 2019.
0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on C WorldWide Group's 13F filing for Q2 2020, filed 5 Aug 2020.